| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (methicillin-resistant) |
0.03 |
0.03 |
0.015 － 0.03 |
Difluoroquinolone (PD 117596)  |
248 |
| Staphylococcus aureus (methicillin-resistant) |
0.03 |
0.03 |
0.015 － 0.06 |
AC98-6446 |
175 |
| Staphylococcus aureus (methicillin-resistant) |
0.03 |
0.06 |
0.015 － 0.06 |
Clinafloxacin (PD 127391) |
248 |
| Staphylococcus aureus (methicillin-resistant) |
0.03 |
0.06 |
≤0.015 － 0.125 |
Dalbavancin |
72 |
| Staphylococcus aureus (methicillin-resistant) |
≤0.06 |
≤0.06 |
≤0.06 － 256 |
Rifampicin (Rifampin) |
497 |
| Staphylococcus aureus (methicillin-resistant) |
0.06 |
0.12 |
0.03 － 0.25 |
Retapamulin |
120 |
| Staphylococcus aureus (Methicillin-resistant) |
0.06 |
0.125 |
0.03 － 0.125 |
Retapamulin |
596 |
| Staphylococcus aureus (Methicillin-resistant) |
0.06 |
0.125 |
0.06 － 0.25 |
Retapamulin |
596 |
| Staphylococcus aureus (methicillin-resistant) |
0.06 |
0.25 |
0.008 － 0.5 |
ACH-702 |
1279 |
| Staphylococcus aureus (methicillin-resistant) |
0.06 |
16 |
≤0.06 － 64 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
396 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.12 |
0.06 － 0.12 |
Retapamulin |
604 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
0.03 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
475 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
0.06 － 1 |
Tigecycline (GAR-936, Tigacyl) |
42 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
0.06 － 8 |
Minocycline (Minocycline hydrochloride, Minocin) |
604 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
<0.12 － 0.25 |
Quinupristin/Dalfopristin (Synercid) |
1060 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
0.12 － 0.25 |
Tigecycline (GAR-936, Tigacyl) |
311 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
0.12 － 1 |
Tigecycline (GAR-936, Tigacyl) |
214 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
? － ? |
Tigecycline (GAR-936, Tigacyl) |
36 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.5 |
0.06 － 1 |
NB2001 |
186 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
8 |
0.03 － 8 |
Moxifloxacin (BAY 12-8039, Avelox) |
1060 |
| Staphylococcus aureus (methicillin-resistant) |
>0.12 |
>8 |
≤0.03 － >8 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
73 |
| Staphylococcus aureus (methicillin-resistant) |
>0.12 |
>16 |
0.03 － >16 |
Clindamycin (Cleocin) |
604 |
| Staphylococcus aureus (methicillin-resistant) |
0.125 |
0.5 |
≤0.06 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
497 |
| Staphylococcus aureus (methicillin-resistant) |
0.13 |
0.13 |
0.06 － 0.5 |
Daptomycin (Cubicin) |
7 |
| Staphylococcus aureus (methicillin-resistant) |
0.13 |
0.25 |
? － ? |
Dalbavancin |
1111 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.25 |
0.06 － 0.5 |
Telavancin (TD-6424, Vibativ) |
73 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.25 |
0.12 － 0.25 |
Sparfloxacin (AT-4140, Zagam) |
374 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.25 |
0.12 － >32 |
Fusidic acid (Fucidin) |
604 |